Please login to the form below

Not currently logged in
Email:
Password:

Takeda considers India deals, says report

India's the Economic Times has reported that Takeda is holding talks with India-based generic drug firms Cipla and Lupin

Takeda Pharmaceutical Company is reportedly in takeover talks with India-based generic drug manufacturers Cipla and Lupin, according to the Economic Times.

Takeda, which has said it wants to expand in India, one of the world's fastest growing drug markets, has reportedly held preliminary talks with Cipla, while talks with Lupin have progressed beyond the initial stage.

The newspaper, which cited individuals with direct knowledge of the development, could not confirm the story with official representatives of the companies. It did, however, quote a Cipla spokeswoman: "We would like to clarify that these reports are baseless and untrue and is categorically denied."

The Economic Times said that Takeda was interested in buying Lupin's domestic formulations business, as well as its research facility, but its founders were not willing to sell the research unit.

The speculation follows news that Sanofi is to expand its role in India with the acquisition of Universal Healthcare's over-the-counter business unit.

For more information about the fast-growing pharmaceutical industry in India, see PMGroup's Country Report: India.

24th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics